Global Active Pharmaceutical Ingredients Market Analysis Report 2024-2030: Synthetic API Segment Dominated the Market with the Largest Revenue Share of 70.6% in 2023
29 avr. 2024 11h31 HE
|
Research and Markets
Dublin, April 29, 2024 (GLOBE NEWSWIRE) -- The "Global Active Pharmaceutical Ingredients Market Size, Share & Trends Analysis Report by Type Of Synthesis (Biotech, Synthetic), Type Of...
George Medicines Appoints Mark Mallon as Chief Executive Officer and Board Director
29 avr. 2024 07h00 HE
|
George Medicines
George Medicines Appoints Mark Mallon as Chief Executive Officer and Board Director London, UK 29 April 2024 – George Medicines, a late-stage, biopharmaceutical company addressing significant unmet...
Active Pharmaceutical Ingredient Market Trends Signal Growth Towards USD 446.6 Billion by 2032 With CAGR AT 6.4%
23 avr. 2024 12h43 HE
|
Dimension Market Research
New York, April 23, 2024 (GLOBE NEWSWIRE) -- Overview According to Dimension Market Research, The Global Active Pharmaceuticals Ingredient Market size was valued USD 249.0 billion in 2023 and it...
Kamari Pharma Announces Abstracts Accepted for Presentation at the 81st Annual Meeting of the Society for Investigative Dermatology
16 avr. 2024 16h05 HE
|
Kamari Pharma
Late breaking poster presentation includes Phase 1b clinical trial results demonstrating the safety and preliminary efficacy of KM-001, a topical TRPV3 inhibitor, for the treatment of palmoplantar...
Optimi Health Achieves Milestone: Completes In-House Production of MDMA Active Pharmaceutical Ingredient (API)
15 avr. 2024 08h00 HE
|
Optimi Health Corp.
Optimi announces completion of three batches of its MDMA API manufactured from raw materials under the Company’s Precursor Licence.
Global Analytical Standards Market Forecast at $2.08 Billion by 2030, Dominated by Merck, Waters Corporation, and Agilent Technologies - Strict Quality Regulations Driving the Market
11 avr. 2024 11h24 HE
|
Research and Markets
Dublin, April 11, 2024 (GLOBE NEWSWIRE) -- The "Global Analytical Standards Market Size, Share & Trends Analysis Report by Category (Organic Analytical Standards, In-organic Analytical...
Novotech Publishes Research Report on Acute Myeloid Leukaemia Clinical Trial Landscape for Clinical Stage Biotechs
10 avr. 2024 22h37 HE
|
Novotech
The report presents a comprehensive look at the AML funding landscape, trial density, patient recruitment data
Novotech Publishes Analyst Report on Cystic Fibrosis Clinical Trial Landscape to Inform Biotech Research Planning
10 avr. 2024 22h33 HE
|
Novotech
The report presents a data-backed review of the Cystic Fibrosis (CF) funding landscape, trial density, and patient recruitment data.
Biognosys and Alamar Biosciences Forge Strategic Partnership in Proteomics to Advance Biopharma and Precision Medicine Research
04 avr. 2024 08h11 HE
|
Biognosys AG
Collaboration brings together Biognosys’ expertise in DIA mass spectrometry and Alamar’s cutting-edge immunoassays to enhance understanding of biomarkers.
Optimi Health Receives Finished Product Test Results and Certificate Of Analysis for GMP Natural Psilocybin Extract
02 avr. 2024 07h30 HE
|
Optimi Health Corp.
Optimi receives Certificate Of Analysis for GMP Natural Psilocybin Extract. Company has also completed the in-house encapsulation of 5mg & 10mg psilocybin.